biomerics

Biomerics is a leading vertically integrated contract manufacturer specializing in the interventional medical device market. Established in 1994, the company is dedicated to delivering innovative solutions for diagnostic and interventional procedures across various medical fields, including cardiovascular, structural heart, cardiac rhythm management, and vascular access. Biomerics' mission is to enhance patient care by providing high-quality, reliable medical devices through comprehensive design, development, and manufacturing services. The company's vision emphasizes a commitment to innovation, quality, and strategic partnerships, positioning itself as a trusted partner to 20 of the top 30 medical device original equipment manufacturers (OEMs) globally.

Biomerics focuses on delivering comprehensive solutions for the interventional medical device market. The company's core objectives include providing engineering design and development services, technology transfer manufacturing services, and contract manufacturing services, encompassing sterilization and packaging. Biomerics specializes in various areas, such as materials and compounding, injection molding, interventional medical plastics, complex extrusion, micromachining of metals and polymers, laser processing, balloons and balloon catheters, advanced catheters and steerables, image-guided intervention, and finished device assembly. The company targets primary markets including cardiovascular, endoscopy, neuromodulation, neurovascular, robotic surgery, structural heart, urology, and vascular access.

Biomerics has demonstrated significant financial growth and strategic investments to expand its capabilities and global footprint. In 2017, the company announced plans to invest $38.5 million over eight years to build a new 230,000-square-foot corporate headquarters in Salt Lake City, Utah, aiming to add over 380 new jobs. In 2022, Biomerics invested $9.5 million to build and equip its second plant in Cartago, Costa Rica, dedicated to medical device solutions for extrusion, injection molding, micromachining metals processing, and final assembly processes in cleanrooms. This expansion was expected to create approximately 250 new jobs in 2022, with plans to reach 1,000 employees by 2024. In 2023, Biomerics completed a 24,000-square-foot expansion of its manufacturing operations in Athens, Texas, driven by growth in the single-use endoscopy market. Additionally, in 2024, the company launched its vertically integrated Metal Injection Molding (MIM) services, further enhancing its commitment to contract design and manufacturing excellence in the metals space.

Biomerics has expanded its technological capabilities through strategic mergers and acquisitions. In 2014, the company merged with Access Point Technologies, creating the Biomerics Advanced Catheter Division to provide next-generation catheter and minimally invasive surgical device solutions. In 2022, Biomerics acquired Dependable Plastics, leading to the creation of the Biomerics Interventional Medical Plastics (IMP) Division, which offers a variety of plastic component technologies including liquid cast resin, advanced thermoforming, injection molding, and additive manufacturing. In 2023, Biomerics announced a merger with Precision Concepts' medical business, expanding its capabilities in micro-metals machining and stamping, injection micro-molding, and micro-assembly processes.

Biomerics' leadership team is composed of experienced professionals dedicated to advancing the company's mission and strategic objectives. Travis Sessions serves as the Chief Executive Officer, overseeing the company's overall direction and growth. Arun Mohan is the President of Biomerics' Micro Metals Division, leading initiatives in metal injection molding and micro-metals processing. Steve Berhow, Founder and President of the Biomerics Advanced Catheter Division, brings extensive expertise in the development and manufacture of advanced catheter components and minimally invasive surgical devices. Brett Poole leads the Biomerics Interventional Medical Plastics Division, focusing on integrating various plastics manufacturing technologies to serve the robotic and interventional markets.

Biomerics operates in a competitive landscape alongside companies such as Zeus Industrial Products, Vision Engineering, ProMed Molded Products, and Tegra Medical. Zeus Industrial Products specializes in precision polymer extrusions and custom tubing. Vision Engineering manufactures ergonomic stereo microscopes and non-contact measuring systems. ProMed Molded Products focuses on medical silicone molding, while Tegra Medical provides end-to-end contract manufacturing solutions for the medical device industry.

Biomerics has established significant collaborations and partnerships to strengthen its market position and innovation capacity. The merger with Access Point Technologies in 2014 led to the creation of the Biomerics Advanced Catheter Division, enhancing the company's capabilities in catheter and minimally invasive surgical device solutions. The acquisition of Dependable Plastics in 2022 resulted in the formation of the Biomerics Interventional Medical Plastics Division, expanding the company's expertise in plastic component technologies. The 2023 merger with Precision Concepts' medical business further extended Biomerics' capabilities in micro-metals machining, injection micro-molding, and micro-assembly processes.

Biomerics' strategic roadmap focuses on expanding its global footprint, enhancing technological capabilities, and strengthening partnerships to drive innovation in the interventional medical device market. The company's investments in new facilities, such as the corporate headquarters in Utah and the second plant in Costa Rica, demonstrate a commitment to growth and meeting the evolving needs of the medical device industry. By leveraging its vertically integrated model and comprehensive engineering expertise, Biomerics is well-positioned to capitalize on emerging opportunities and deliver high-quality solutions to its global customer base.

For more information, visit Biomerics' official website.